SCHEMBL1047773

SCHEMBL1047773

c1ccc(C2=NN2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21679634 0.97 RAB9A (0.46)
SCHEMBL26097912 0.83 NPC1 (0.39)
Benzamidine SCHEMBL482740 0.78 F2 (0.61)
SCHEMBL27985320 0.78 NISCH (0.38)
SCHEMBL11154267 0.73 NISCH (0.44)
Biphenyl SCHEMBL1358618 0.67 ALDH1A1 (1.00)
Biphenyl SCHEMBL2548048 0.67 ALDH1A1 (1.00)
Biphenyl SCHEMBL4002609 0.67 ALDH1A1 (1.00)
SCHEMBL30108088 0.67 ALDH1A1 (1.00)
Biphenyl SCHEMBL164 0.67 ALDH1A1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713681-A2 METHOD FOR PHOTOLABELING BIOMOLECULES USING PHOTOREACTIVE PROBES Syncell (Taiwan) Inc. (TW) 2026-03-25 EP claimed
US-20250362302-A1 INTRACELLULAR LIGATION OF PHOTOCATALYSTS FOR PHOTO-RESPONSIVE, PROBE-MEDIATED PROTEIN LABELING SEED THERAPEUTICS US INC (US) 2025-11-27 US claimed
EP-4540613-A1 INTRACELLULAR LIGATION OF PHOTOCATALYSTS FOR PHOTO-RESPONSIVE, PROBE-MEDIATED PROTEIN LABELING Seed Therapeutics US, Inc. (US) 2025-04-23 EP claimed
WO-2025006872-A2 METHOD FOR PHOTOLABELING BIOMOLECULES USING PHOTOREACTIVE PROBES Syncell (Taiwan) Inc. (TW) 2025-01-02 WO claimed
WO-2023245020-A1 INTRACELLULAR LIGATION OF PHOTOCATALYSTS FOR PHOTO-RESPONSIVE, PROBE-MEDIATED PROTEIN LABELING SEED THERAPEUTICS US, INC. (US) 2023-12-21 WO claimed
US-20230257416-A1 METHODS OF GENERATING NANOARRAYS AND MICROARRAYS NAUTILUS SUBSIDIARY, INC. 2023-08-17 US claimed
US-20220326576-A1 ALIGNMENT FILM MATERIAL AND LIQUID CRYSTAL DISPLAY DEVICE JAPAN DISPLAY INC. (JP) 2022-10-13 US claimed
US-9296870-B2 Modification of surfaces with nanoparticles THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-03-29 US claimed
US-8507572-B2 Functionalization of organic surfaces THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2013-08-13 US claimed
EP-1911768-B1 Protein, method for immobilizing protein, structure, biosensor, nucleic acid, vector and kit for detecting target substance CANON KK (JP) 2011-12-14 EP claimed
US-7868142-B2 Protein, method for immobilizing protein, structure, biosensor, nucleic acid, vector and kit for detecting target substance CANON KABUSHIKI KAISHA (JP) 2011-01-11 US claimed
US-20100331441-A1 FUNCTIONALIZATION OF ORGANIC SURFACES COLUMBIA UNIVERSITY (US) 2010-12-30 US claimed
US-20080187461-A1 PROTEIN, METHOD FOR IMMOBILIZING PROTEIN, STRUCTURE, BIOSENSOR, NUCLEIC ACID, VECTOR AND KIT FOR DETECTING TARGET SUBSTANCE CANON KABUSHIKI KAISHA (JP) 2008-08-07 US claimed
EP-1911768-A1 Protein, method for immobilizing protein, structure, biosensor, nucleic acid, vector and kit for detecting target substance Canon Kabushiki Kaisha (JP) 2008-04-16 EP claimed
EP-1100819-B1 ANTAGONISTS SPECIFIC FOR THE CORTICOTROPIN-RELEASING FACTOR RECEPTOR TYPE 2 (CRFR2) MAX PLANCK GESELLSCHAFT (DE) 2007-02-21 EP claimed
US-6903223-B1 Phenyldiazirine compounds and photoaffinity labeling reagent SEIKAGAKU CORPORATION (JP) 2005-06-07 US claimed
US-6846803-B1 Antagonists specific for the corticotropin-releasing factor receptor type 2 (CRFR2) MAX PLANCK GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2005-01-25 US claimed
EP-1100819-A2 ANTAGONISTS SPECIFIC FOR THE CORTICOTROPIN-RELEASING FACTOR RECEPTOR TYPE 2 (CRFR2) Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2001-05-23 EP claimed
WO-2000005253-A9 ANTAGONISTS SPECIFIC FOR THE CORTICOTROPIN-RELEASING FACTOR RECEPTOR TYPE 2 (CRFR2) MAX PLANCK GESELLSCHAFT (DE) 2000-07-27 WO claimed
WO-2000005253-A2 ANTAGONISTS SPECIFIC FOR THE CORTICOTROPIN-RELEASING FACTOR RECEPTOR TYPE 2 (CRFR2) MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2000-02-03 WO claimed